Morph study days are sponsored by pharmaceutical companies, who provide funding that allows them to offer all events completely free of charge. Sponsors have no involvement in agenda development, speaker selection, or clinical content – this is managed entirely by MORPh’s clinical team.

 

The “Endocrinology in Primary Care Thyroid, Osteoporosis & Injectable Therapies ” webinar is free to access for all registered healthcare professionals that have a MORPh Account.

The webinar will be open from 18:30 for welcome and introductions the training will begin shortly after. Our expert speakers will be discussing the following topics:

Learning Objectives  

  • Enhance clinical confidence in managing thyroid disorders in primary care, including correct interpretation of thyroid function tests and safe titration of levothyroxine in hypothyroidism. 
  • Improve identification and management of osteoporosis, including appropriate referral for DEXA scanning, interpretation of reports, recognition of red flags, and initiation of preventative treatment where indicated. 
  • Develop safe and confident prescribing practices for injectable therapies in diabetes and weight management, including understanding indications, mechanisms of action, dose titration, switching strategies and emerging evidence. 

Thyroid & Osteoporosis Update

  • Comprehensive overview of primary care focused thyroid conditions & Osteoporosis  
  • Managing hypothyroidism – Interpreting pathology results & titrating levothyroxine 
  • When to consider osteoporosis, referring & interpreting DEXA reports and when is preventative treatment indicated without use of scanning 
  • Red flags, safety netting & example notes level documentation of reviews 
  • Useful guidelines & resources 

Injectable therapies in weight loss and diabetes: confident conversations and prescribing 

  • Indications for use of GLP1/GIP medications in diabetes and weight management – national & local guidelines  
  • Mechanism of action, dosing & administration  
  • Switching between options & deprescribing  
  • Dose titrations, side effects & recent evidence on known risks of use 
  • Future medications/new clinical trials